Coral improves drug development and deployment by utilizing genomic data from patients to determine how they will respond to a drug before they get treated.
It unlocks value-based medication solutions that improve access and align incentives.
Company Details
- Founded
- 2018
- Address
- 953 Indiana St, San Francisco,california 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- coralgenomics.com
- HQ
- San Francisco, California
Coral (Acquihired) Questions
Coral (Acquihired)'s website is coralgenomics.com
Coral (Acquihired)'s LinkedIn profile is https://www.linkedin.com/company/coral-genomics
Coral (Acquihired)'s industry is
Biotechnology Research
Coral (Acquihired)'s top competitors are
Alix Ventures,
Xaira Therapeutics,
Mammoth Biosciences,
Siren Biotechnology,
Retro Biosciences,
Toi Labs,
Scribio,
Gordian Biotechnology,
Amber Bio,
Oncko.
Coral (Acquihired)'s categories are Biotechnology Research
Coral (Acquihired)'s founding year is 2018
